CALL FOR PAPERS Cardiovascular Consequences of Obesity and Type 2 Diabetes Angiotensin-(1–7) treatment mitigates right ventricular fibrosis as a distinctive feature of diabetic cardiomyopathy

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.

  2014cited by this paper
• Angiotensin II-Induced Production of Mitochondrial Reactive Oxygen Species: Potential Mechanisms and Relevance for Cardiovascular Disease

  2013cited by this paper
• Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus.

  2013cited by this paper
• Non-ACE pathway-induced angiotensin II production.

  2013cited by this paper
• Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1.

  2012cited by this paper
• Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy.

  2012cited by this paper
• Na / Ca 2 exchanger-1 protects against systolic failure in the Akitains 2 model of diabetic cardiomyopathy via a CXCR 4 / NF-B pathway

  2012cited by this paper
• Right Ventricular Structure Is Associated With the Risk of Heart Failure and Cardiovascular Death: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study

  2012cited by this paper
• Beneficial effects of angiotensin (1–7) in diabetic rats with cardiomyopathy

  2011cited by this paper
• TRB 3 Gene Silencing Alleviates Diabetic Cardiomyopathy in a Type 2 Diabetic Rat Model

  2011cited by this paper
• ACE2 Improves Right Ventricular Function in a Pressure Overload Model

  2011cited by this paper
• Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction

  2010cited by this paper
• Angiotensin-(1-7) improves cardiac remodeling and inhibits growth-promoting pathways in the heart of fructose-fed rats.

  2010cited by this paper
• The angiotensin-converting enzyme 2/angiogenesis-(1-7)/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension.

  2010cited by this paper
• The role of secondary heart field in cardiac development.

  2009cited by this paper
• Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension.

  2009cited by this paper
• Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban.

  2009cited by this paper
• B-type natriuretic peptide, a marker of asymptomatic left ventricular dysfunction in type 2 diabetic patients.

  2008cited by this paper
• Estimating pulmonary artery pressures by echocardiography in patients with emphysema

  2007cited by this paper
• Role of changes in cardiac metabolism in development of diabetic cardiomyopathy.

  2006cited by this paper
• A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity.

  2005cited by this paper
• Evidence of Left Ventricular Dysfunction in Asymptomatic Elderly Patients with Non-insulin-dependent Diabetes Mellitus

  2004cited by this paper
• Nonpeptide AVE 0991 Is an Angiotensin-(1–7) Receptor Mas Agonist in the Mouse Kidney

  2004cited by this paper
• Development of intramolecularly quenched fluorescent peptides as substrates of angiotensin-converting enzyme 2.

  2003cited by this paper
• Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas

  2003cited by this paper
• Perindopril Alters Vascular Angiotensin-Converting Enzyme, AT1 Receptor, and Nitric Oxide Synthase Expression in Patients With Coronary Heart Disease

  2002cited by this paper
• AVE 0991, a Nonpeptide Mimic of the Effects of Angiotensin-(1–7) on the Endothelium

  2002cited by this paper
• Impact of right ventricular involvement on mortality and morbidity in patients with inferior myocardial infarction.

  2001cited by this paper
• The outflow tract of the heart is recruited from a novel heart-forming field.

  2001cited by this paper
• Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II.

  1999cited by this paper
• Right ventricular ejection fraction is an independent predictor of survival in patients with moderate heart failure.

  1998cited by this paper
• Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.

  1995cited by this paper
• Comparison of contractile state and myosin isozymes of rat right and left ventricular myocardium.

  1987cited by this paper
• Faster Time to Peak Tension and Velocity of Shortening in Right Versus Left Ventricular: Trabeculae and Papillary Muscles of Dogs

  1986cited by this paper

• Right ventricular dysfunction in type 1 diabetic cardiomyopathy: An overlooked component?

  2026cites this paper
• Novel insights into the central protective role of ACE2 in diabetic cardiomyopathy: from underlying signaling pathways to therapeutic perspectives

  2025cites this paper
• Right ventricular dysfunctions in type 1 diabetic mice: A longitudinal study

  2025cites this paper
• Unraveling the interplay between RAS axes and NOX signaling in fibroblasts during cardiac fibrosis

  2025influential citation
• Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article

  2025cites this paper
• ADAM17 knockdown is more effective than AT1R blocker in alleviating diabetic cardiomyopathy through downregulating the RhoA-ROCK1 pathway.

  2025cites this paper
• Update on clinical and experimental management of diabetic cardiomyopathy: addressing current and future therapy

  2024cites this paper
• The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

  2024cites this paper
• Angiotensin-II type 2 receptor-mediated renoprotection is independent of receptor Mas in obese Zucker rats fed high-sodium diet

  2024cites this paper
• Chrysin-based supramolecular cyclodextrin-calixarene drug delivery system: a novel approach for attenuating cardiac fibrosis in chronic diabetes

  2023cites this paper
• Regional changes in cellular and molecular pathology in children with end-stage dilated cardiomyopathy: Correlation with regional and global cardiac performance

  2023cites this paper
• CCAAT/Enhancer-Binding Proteins in Fibrosis: Complex Roles Beyond Conventional Understanding

  2022cites this paper
• CHARACTERIZATION OF CIRCULATING FIBROCYTES IN PEOPLE LIVING WITH HIV A THESIS SUBMITTED TO THE GRADUATE DIVISION OF THE UNIVERITY OF HAWAII AT MANOA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE

  2022cites this paper
• ADAM17 knockdown mitigates while ADAM17 overexpression aggravates cardiac fibrosis and dysfunction via regulating ACE2 shedding and myofibroblast transformation

  2022cites this paper
• Lymphatic Collecting Vessel: New Perspectives on Mechanisms of Contractile Regulation and Potential Lymphatic Contractile Pathways to Target in Obesity and Metabolic Diseases

  2022cites this paper
• Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system

  2021cites this paper
• Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1–7)-Mas Axis in Pulmonary Arterial Hypertension

  2021cites this paper
• The role of SARS‐CoV‐2 target ACE2 in cardiovascular diseases

  2021cites this paper
• Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury

  2021cites this paper
• Angiotensin (1-7) Alleviates Postresuscitation Myocardial Dysfunction by Suppressing Oxidative Stress Through the Phosphoinositide 3-Kinase, Protein Kinase B, and Endothelial Nitric Oxide Synthase Signaling Pathway

  2021cites this paper
• Angiotensin IV attenuates diabetic cardiomyopathy via suppressing FoxO1-induced excessive autophagy, apoptosis and fibrosis

  2021cites this paper
• Prolylcarboxypeptidase Mitigates Myocardial Ischemia/Reperfusion Injury by Stabilizing Mitophagy

  2020cites this paper
• A comprehensive guide to the pharmacologic regulation of angiotensin converting enzyme 2 (ACE2), the SARS-CoV-2 entry receptor

  2020cites this paper
• Roles of sarcoplasmic reticulum Ca2+ ATPase pump in the impairments of lymphatic contractile activity in a metabolic syndrome rat model

  2020cites this paper
• Efficacy of lanthionine‐stabilized angiotensin‐(1–7) in type I and type II diabetes mouse models

  2019cites this paper
• Molecular Mechanisms Responsible for Diastolic Dysfunction in Diabetes Mellitus Patients

  2019cites this paper
• Angiotensin-(1-7) and the Heart

  2019cites this paper
• Liraglutide alleviates cardiac fibrosis through inhibiting P4h&agr;-1 expression in STZ-induced diabetic cardiomyopathy

  2019cites this paper
• Dimerization of AT2 and Mas Receptors in Control of Blood Pressure

  2018cites this paper
• Ang-(1-7) protects HUVECs from high glucose-induced injury and inflammation via inhibition of the JAK2/STAT3 pathway.

  2018cites this paper
• Angiotensin-(1-7) and the Regulation of Anti-Fibrotic Signaling Pathways.

  2017cites this paper
• Therapeutic Approaches to the Alternative Angiotensin-(1–7) Axis of the Renin-Angiotensin System

  2017cites this paper
• Fibroblasts and the extracellular matrix in right ventricular disease

  2017cites this paper
• Angiotensin-converting enzyme 2 overexpression protects against doxorubicin-induced cardiomyopathy by multiple mechanisms in rats

  2017cites this paper
• Effects of renal denervation on cardiac oxidative stress and local activity of the sympathetic nervous system and renin-angiotensin system in acute myocardial infracted dogs

  2017cites this paper
• The Renin Angiotensin System and Diabetes

  2017cites this paper
• CCAAT/enhancer‐binding protein β overexpression alleviates myocardial remodelling by regulating angiotensin‐converting enzyme‐2 expression in diabetes

  2017cites this paper
• Protective effect of angiotensin-(1-7) against hyperglycaemia-induced injury in H9c2 cardiomyoblast cells via the PI3K/Akt signaling pathway

  2017cites this paper
• The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)

  2017cites this paper
• Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease

  2016cites this paper
• Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.

  2016cites this paper
• Noninvasive ventilation improves cardiac function in patients with chronic heart failure

  2016cites this paper
• Role of Circulating Fibrocytes in Cardiac Fibrosis

  2016cites this paper
• Fn14 is regulated via the RhoA pathway and mediates nuclear factor-kappaB activation by Angiotensin II.

  2016cites this paper
• Chamber-specific changes in calcium-handling proteins in the type 2 diabetic human heart with preserved ejection fraction.

  2015cites this paper
• World Journal of Diabetes

  year unknowncites this paper